64Cu-CB-TE2A-sst2-ANT

N/A

Report date: 2025/11/20 16:04:37

NME

Base Information

Drug Name64Cu-CB-TE2A-sst2-ANT

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 binders

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWashington University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of Medicine

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A